{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:32:52Z","timestamp":1766050372487,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003385","name":"University of G\u00f6ttingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Psychiatric autoimmune encephalitis (pAE) is a growing field of interest in diagnosis and therapy in psychiatric hospitals and institutions. This study investigates the relevant extent to which there are potential biomarkers in cerebrospinal fluid (CSF) that can differentiate against a cohort with neurodegenerative disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included in this study a total of 27 patients with possible and definite psychiatric autoimmune encephalitis and compared with a cohort with CSF-based AD (<jats:italic>n<\/jats:italic> =\u200927) different biomarkers in CSF such as lactate, cell count, % lymphocytes, % monocytes, total protein content, albumin, immunoglobulins G (IgG), M (IgM) and A (IgA), CSF\/serum albumin ratio, CSF\/serum IgG ratio, CSF\/serum IgA ratio, intrathecal IgG synthesis, blood\u2013brain barrier disruption, specific antibody synthesis for measles, rubella, herpes simplex virus, varicella zoster virus, Ebstein-Barr virus and cytomegalovirus, total tau protein (t-tau), phosphorylated tau protein 181 (p-tau181), amyloid beta 42 (A\u00df42), amyloid beta 40 (A\u00df40) and the amyloid beta 42\/ amyloid beta 40 (A\u00df42\/40) ratio.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The p-tau 181 was elevated above cut-off values in both possible pAE and AD. However, in definitive pAE, p-tau181 levels were not elevated. When elevated p-tau181 levels in possible AE were compared with those in AD, we found relevant differences, such as a relative increase in p-tau181 in AD patients. Elevated p-tau181 levels were detected in possible psychiatric AEs with IgLON5, glycine, recoverin, titin, and nonspecific neuropil antibodies in serum and IgLON5, titin, Yo, and nonspecific neuropil autoantibodies in CSF. In addition, we detected elevated levels of p-tau181 and IgLON5 autoantibodies in serum and CSF, and Yo autoantibodies in CSF in patients with definitive pAE. Interestingly, we observed a higher CSF\/serum IgM ratio in possible and definitive pAE than in AD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggest that neuroaxonal brain damage may occur in specific psychiatric AEs associated with IgLON5, glycine, recoverin, and titin autoantibodies. Further research should focus on the CSF\/serum IgM ratio as an early marker of autoantibody production in pAE compared to AD as a potential biomarker for differential diagnosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1165153","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T04:24:52Z","timestamp":1686284692000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Cerebrospinal fluid biomarkers in psychiatric autoimmune encephalitis: a retrospective cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Niels","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron Levin","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Insa Maria","family":"Grenzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Teegen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Fitzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/s41380-021-01396-4","article-title":"Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany","volume":"27","author":"Endres","year":"2022","journal-title":"Mol Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1055\/a-1400-8393","article-title":"Psychiatrische Autoimmunenzephalitis -Diagnose und therapeutische Ans\u00e4tze","volume":"17","author":"Hansen","year":"2023","journal-title":"PSYCHupdate2"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/ene.12942","article-title":"Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis","volume":"23","author":"Constantinescu","year":"2016","journal-title":"Eur J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e2546","DOI":"10.1212\/WNL.0000000000011937","article-title":"Prospective quantification Of CSF biomarkers in antibody-Mediated Encephalitis","volume":"96","author":"Day","year":"2021","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e1265","DOI":"10.1212\/WNL.0000000000200892","article-title":"Association of microglial activation with spontaneous aria-e and CSF levels of anti-a\u03b2 autoantibodies","volume":"99","author":"Piazza","year":"2022","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1809","DOI":"10.1212\/WNL.0000000000012778","article-title":"Spontaneous ARIA-like events in cerebral Amyloid angiopathy-related inflammation: a multicenter prospective longitudinal cohort study","volume":"97","author":"Antolini","year":"2021","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e1039","DOI":"10.1212\/NXI.0000000000001039","article-title":"Autoimmune encephalitis resembling dementia syndromes","volume":"8","author":"Bastiaansen","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1756286421998906","DOI":"10.1177\/1756286421998906","article-title":"Autoimmune encephalopathies presenting as dementia of subacute onset and rapid progression","volume":"14","author":"Banks","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","article-title":"Autoimmune encephalitis misdiagnosis in adults","volume":"80","author":"Flanagan","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the international working group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-022-00985-9","article-title":"Physiological roles of \u03b2-amyloid in regulating Synaptic function: implications for AD pathophysiology","author":"Cai","year":"2022","journal-title":"Neurosci Bull"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12987-022-00318-y","article-title":"Decreased CSF clearance and increased brain amyloid in Alzheimer's disease","volume":"19","author":"Li","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.mcn.2012.01.007","article-title":"A\u03b242 production in brain capillary endothelial cells after oxygen and glucose deprivation","volume":"49","author":"Bulbarelli","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"837376","DOI":"10.3389\/fimmu.2022.837376","article-title":"Cerebrospinal fluid total tau protein correlates with longitudinal, progressing cognitive dysfunction in anti-neural autoantibody-associated dementia and Alzheimer's dementia: a case-control study","volume":"13","author":"Hansen","year":"2022","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/ene.15469","article-title":"Alzheimer's disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt-Jakob disease and autoimmune encephalitis","volume":"29","author":"Chang","year":"2022","journal-title":"Eur J Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"864769","DOI":"10.3389\/fpsyt.2022.864769","article-title":"Prevalence of anti-neural autoantibodies in a psychiatric patient cohort-paradigmatic application of criteria for autoimmune-based psychiatric syndromes","volume":"13","author":"Hansen","year":"2022","journal-title":"Front Psych"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ana.23857","article-title":"Anti-amyloid \u03b2 autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies","volume":"73","author":"Piazza","year":"2013","journal-title":"Ann Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"100462","DOI":"10.1016\/j.bbih.2022.100462","article-title":"Symposium planning committee members. Infection and inflammation: New perspectives on Alzheimer's disease","volume":"22","author":"Whitson","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/JAD-221091","article-title":"Parkinson\u2019s study group and the Alzheimer\u2019s Disease neuroimaging initiative. early detection of Alzheimer's Disease-related pathology using a multi-disease diagnostic platform employing autoantibodies as blood-based biomarkers","volume":"92","author":"DeMarshall","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/ana.26223","article-title":"Neuropathological variability within a spectrum of NMDAR-encephalitis","volume":"90","author":"Zrzavy","year":"2021","journal-title":"Ann Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.seizure.2020.12.009","article-title":"Serum biomarkers of cerebral cellular stress after self-limiting tonic clonic seizures: an exploratory study","volume":"85","author":"Nass","year":"2021","journal-title":"Seizure"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.eplepsyres.2015.04.004","article-title":"Effect of epileptic seizures on the cerebrospinal fluid--a systematic retrospective analysis","volume":"114","author":"Tumani","year":"2015","journal-title":"Epilepsy Res"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1165153\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T04:24:54Z","timestamp":1686284694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1165153\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":25,"alternative-id":["10.3389\/fpsyt.2023.1165153"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1165153","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"article-number":"1165153"}}